World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 18 May 2020
Main ID:  ISRCTN12929657
Date of registration: 08/09/2014
Prospective Registration: No
Primary sponsor: NutsOhra Foundation (Fonds NutsOhra) (Netherlands)
Public title: Virtual Reality Exposure Therapy in Psychosis
Scientific title: The effect of Virtual Reality Exposure Therapy (VRET) on social participation in people with a psychotic disorder: a multi-site randomized controlled trial
Date of first enrolment: 01/04/2014
Target sample size: 160
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN12929657
Study type:  Interventional
Study design:  Randomised controlled trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Netherlands
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Mark    van der Gaag
Address:  van der Boechorststraat 1 1081 BT Amsterdam Netherlands
Telephone: +31 (0) 64 578 04 63
Email: m.vander.gaag@vu.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Aged 18 to 65 years, either sex
2. Fullfilling diagnostic criteria for a psychotic disorder
3. Experiencing at least mild paranoia and/or social anxiety as measured with the Green et al. Paranoid Thought Scales (GPTS) and Social Interaction Anxiety Scale (SIAS)

Exclusion criteria:
1. IQ under 70
2. Insufficient command of the Dutch language
3. Epilepsy


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Psychotic disorders with continuing social withdrawal
Mental and Behavioural Disorders
Intervention(s)
In both arms treatment as usual will be provided for the psychotic disorder for which the person sought help. In the first experimental arm there will be a maximum of 16 sessions (over three months) of Virtual Reality Exposure Treatment with a trained CBT therapist aimed at improving social participation. Treatment duration is three months, patients will be followed-up at 3 months. The second arm entails a waiting list for a period of six month, after which these participants will also get the VRET treatment.
Primary Outcome(s)

1. Experience Sampling Method (ESM) on social participation.
2. Objective social participation is expressed as the amount of time spend with other people and the type of company (for example family, friends, colleagues or strangers).
3. Subjective social participation is expressed as momentary paranoia, perceived social threat and event stress as experienced in social situations.

All measures are measured at baseline, at end of treatment at 3 months, and at follow-up at 6 months.
Secondary Outcome(s)

1. Depression (BDI-II)
2. Stigmatisation and schemata (ISMI, BCSS)
3. Paranoia (GPTS)
4. Social interaction anxiety (SIAS)
5. Cognitive biases (DACOBS)
6. Safety behavior (Safety Behavior Questionnaire ? persecutory delusions)
7. Quality of life and cost-effectiveness (MANSA,TIC-P)
8. Presence and cyber sickness (SSQ, IPQ), measured at month 1 and at month 2 during treatment.
9. Psychosis (Positive and Negative symptom scales)
10. Social functioning (Social and Occupational Functioning Assessment Scales)
Secondary ID(s)
001
Source(s) of Monetary Support
Fonds NutsOhra (Netherlands)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Medical Ethical Committee of VU Medical Center; 06/03/2014; NL45965.029.13 / 2014.015
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history